What is the best pharmacologic treatment for sickle cell disease pain crises? (åpner nytt vindu)

Baker M, Hafner JW.

Kilde‎: Ann Emerg Med 2012;59(6):515-6.

Arkiv‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (åpner nytt vindu)

Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate. (åpner nytt vindu)

Frei-Jones MJ, Field JJ, DeBaun MR.

Kilde‎: Pediatr Blood Cancer 2009;53(3):401-5.

Arkiv‎: PubMed 19422031

DOI‎: 10.1002/pbc.22048

https://www.ncbi.nlm.nih.gov/pubmed/19422031 (åpner nytt vindu)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (åpner nytt vindu)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Kilde‎: Thromb Haemost 2007;98(2):392-6.

Arkiv‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (åpner nytt vindu)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (åpner nytt vindu)

Okomo U, Meremikwu MM.

Kilde‎: Cochrane Database Syst Rev 2012;(6):CD005406.

Arkiv‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (åpner nytt vindu)

Guidelines for the management of the acute painful crisis in sickle cell disease. (åpner nytt vindu)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Kilde‎: Br J Haematol 2003;120(5):744-52.

Arkiv‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (åpner nytt vindu)

The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome. (åpner nytt vindu)

Ahmad FA, Macias CG, Allen JY.

Kilde‎: J Pediatr Hematol Oncol 2011;33(6):415-20.

Arkiv‎: PubMed 21792036

DOI‎: 10.1097/MPH.0b013e31821ed4ce

https://www.ncbi.nlm.nih.gov/pubmed/21792036 (åpner nytt vindu)

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (åpner nytt vindu)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Kilde‎: Hemoglobin 2004;28(2):85-102.

Arkiv‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (åpner nytt vindu)

Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. (åpner nytt vindu)

Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR.

Kilde‎: Blood 1998;92(9):3082-9.

Arkiv‎: PubMed 9787142

https://www.ncbi.nlm.nih.gov/pubmed/9787142 (åpner nytt vindu)

A short course of prednisone in the management of acute chest syndrome of sickle cell disease. (åpner nytt vindu)

Kumar R, Qureshi S, Mohanty P, Rao SP, Miller ST.

Kilde‎: J Pediatr Hematol Oncol 2010;32(3):e91-4.

Arkiv‎: PubMed 20216237

DOI‎: 10.1097/MPH.0b013e3181c29c52

https://www.ncbi.nlm.nih.gov/pubmed/20216237 (åpner nytt vindu)

A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. (åpner nytt vindu)

Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP.

Kilde‎: Haematologica 2013;98(9):1375-82.

Arkiv‎: PubMed 23645695

DOI‎: 10.3324/haematol.2013.086637

https://www.ncbi.nlm.nih.gov/pubmed/23645695 (åpner nytt vindu)

Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. (åpner nytt vindu)

Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, Brugnara C.

Kilde‎: JAMA 2003;289(9):1136-42.

Arkiv‎: PubMed 12622584

https://www.ncbi.nlm.nih.gov/pubmed/12622584 (åpner nytt vindu)

Predictors of bacteremia in febrile children with sickle cell disease. (åpner nytt vindu)

West DC, Andrada E, Azari R, Rangaswami AA, Kuppermann N.

Kilde‎: J Pediatr Hematol Oncol 2002;24(4):279-83.

Arkiv‎: PubMed 11972096

https://www.ncbi.nlm.nih.gov/pubmed/11972096 (åpner nytt vindu)